To date, the Company has not received reports of any adverse events related to this recall. Fresenius Kabi is voluntarily recalling 7 lots of Sodium Acetate Injection, USP, 400mEq/100mL (4mEq/mL ...

Gentisic acid (5 mg ml −1 in 0.25 M sodium acetate buffer ... into a glass 'reaction vial'. The pH of the labeling reaction should be in the range of 6.8–7.2 for optimal labeling efficiency.

Finding particulate matter in vials of Sodium Acetate Injection caused Chicago-area company Fresenius Kabi to recall seven lots of the sodium additive. Sodium Acetate Injection, USP, 400 mEq/100 ...

Hikma has launched sodium acetate injection in 40 mEq per 20 mL vials in the United States. The product was approved with a Competitive Generic Therapy designation from the Food and Drug ...

Food and Drug Administration said. The recall involves Sodium Acetate Injection, USP 400 mEq/100 mL (4 mEq/mL), 100 mL fill in a 100 mL vial. Sodium Acetate Injection, USP is indicated as a source ...

The suspect vial was punctured but not administered ... Earlier in March, meanwhile, Fresenius Kabi yanked seven lots of sodium acetate intravenous fluid in the U.S. because testing revealed ...

0.1M solutions of NaCl (sodium chloride), NaC2H3O2 (sodium acetate), and NH4Cl (ammonium chloride ... Transfer 20-25mL of solutions into labeled, screw-top vials. Bubble nitrogen gas through the ...